MedTrace Logo

The Effects of Mirror Therapy on Upper Extremity in Stroke Patients

NCT01656876 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-11-05

No results posted yet for this study

Summary

The purpose of this study is to compare treatment efficacy of mirror therapy (MT), mirror therapy combining mesh glove (MG+MT) stimulation, and controlled treatment (CT) in people with stroke.

Conditions

  • Cerebrovascular Accident

Interventions

BEHAVIORAL

Mirror box training

This protocol includes 1 hour mirror therapy and 0.5 hour functional training in a session. The treatment intensity is 1.5 hours/day, 5 days/week, for 4 weeks. MT focuses on symmetrical bimanual movements and simultaneously observing the visual feedback of the unaffected upper extremity reflected by the mirror.

OTHER

mesh glove stimulation

The MG is a two-channel electrical stimulator providing synchronous or reciprocal sensory stimulation with variant amplitudes.

BEHAVIORAL

conventional intervention

Participants in this group receive a structured protocol based on occupational therapy such as neuro-developmental techniques and task-oriented approach

Sponsors & Collaborators

  • Taipei Medical University Hospital

    lead OTHER

Principal Investigators

  • Tsan-hon Liou, PhD · Shuang-Ho Hospital, Taipei Medical University

  • Ching-yi Wu, ScD · Department of Occupational Therapy, College of Medicine, Chang Gung University

  • Keh-chung Lin, ScD · School of Occupational Therapy, College of Medicine, National Taiwan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656876 on ClinicalTrials.gov